Us Bancorp \De\ Integra Lifesciences Holdings Corp Transaction History

Us Bancorp \De\

$82.9 Billion
Q3 2025

A detailed history of Us Bancorp \De\ transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Us Bancorp \De\ holds 3,144 shares of IART stock, worth $36,942. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,144

Previous 2,056 52.92%

Holding current value

$36,942

Previous $25,000 80.0%

% of portfolio

0.0%

Previous 0.0%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	BUY	$11.13 - $15.99 $12,109 - $17,397	1,088 Added 52.92%	3,144 $45,000
Q2 2025 Jul 23, 2025	SELL	$11.6 - $21.78 $17,666 - $33,170	-1,523 Reduced 42.55%	2,056 $25,000
Q1 2025 May 08, 2025	BUY	$21.13 - $26.55 $10,100 - $12,690	478 Added 15.41%	3,579 $78,000
Q4 2024 Feb 05, 2025	BUY	$16.95 - $26.7 $4,237 - $6,675	250 Added 8.77%	3,101 $70,000
Q3 2024 Oct 28, 2024	BUY	$17.14 - $31.74 $6,787 - $12,569	396 Added 16.13%	2,851 $51,000

Q2 2024 Aug 06, 2024	BUY	$23.14 - $34.72 $8,955 - $13,436	387 Added 18.71%	2,455 $71,000
Q1 2024 May 07, 2024	SELL	$33.4 - $45.2 $8,717 - $11,797	-261 Reduced 11.21%	2,068 $73,000
Q4 2023 Feb 09, 2024	BUY	$34.21 - $44.59 $1,710 - $2,229	50 Added 2.19%	2,329 $101,000
Q3 2023 Nov 03, 2023	SELL	$37.8 - $45.97 $140,842 - $171,284	-3,726 Reduced 62.05%	2,279 $87,000
Q2 2023 Aug 09, 2023	SELL	$37.95 - $58.98 $32,105 - $49,897	-846 Reduced 12.35%	6,005 $246,000
Q1 2023 May 09, 2023	SELL	$52.61 - $60.49 $11,679 - $13,428	-222 Reduced 3.14%	6,851 $393,000
Q4 2022 Feb 13, 2023	BUY	$42.17 - $58.6 $3,921 - $5,449	93 Added 1.33%	7,073 $396,000
Q3 2022 Oct 27, 2022	SELL	$42.28 - $57.17 $41,180 - $55,683	-974 Reduced 12.25%	6,980 $296,000
Q2 2022 Aug 01, 2022	BUY	$53.86 - $66.52 $30,807 - $38,049	572 Added 7.75%	7,954 $430,000
Q1 2022 May 11, 2022	SELL	$62.86 - $69.24 $8,988 - $9,901	-143 Reduced 1.9%	7,382 $474,000
Q4 2021 Feb 11, 2022	SELL	$62.47 - $73.25 $20,365 - $23,879	-326 Reduced 4.15%	7,525 $504,000
Q3 2021 Nov 10, 2021	SELL	$64.97 - $76.19 $779 - $914	-12 Reduced 0.15%	7,851 $539,000
Q2 2021 Aug 05, 2021	SELL	$66.79 - $76.63 $139,190 - $159,696	-2,084 Reduced 20.95%	7,863 $536,000
Q1 2021 Apr 28, 2021	SELL	$62.63 - $71.15 $73,464 - $83,458	-1,173 Reduced 10.55%	9,947 $688,000
Q4 2020 Feb 04, 2021	SELL	$43.31 - $66.55 $50,109 - $76,998	-1,157 Reduced 9.42%	11,120 $721,000
Q3 2020 Nov 10, 2020	SELL	$43.33 - $51.72 $7,972 - $9,516	-184 Reduced 1.48%	12,277 $580,000
Q2 2020 Aug 07, 2020	BUY	$41.42 - $55.57 $98,413 - $132,034	2,376 Added 23.56%	12,461 $586,000
Q1 2020 May 13, 2020	BUY	$36.67 - $61.04 $135,458 - $225,481	3,694 Added 57.8%	10,085 $451,000
Q4 2019 Feb 04, 2020	BUY	$55.73 - $62.49 $29,202 - $32,744	524 Added 8.93%	6,391 $372,000
Q3 2019 Nov 08, 2019	SELL	$53.29 - $64.59 $8,632 - $10,463	-162 Reduced 2.69%	5,867 $352,000
Q2 2019 Aug 13, 2019	SELL	$46.45 - $55.85 $19,462 - $23,401	-419 Reduced 6.5%	6,029 $336,000
Q1 2019 May 08, 2019	SELL	$42.97 - $57.33 $20,754 - $27,690	-483 Reduced 6.97%	6,448 $359,000
Q4 2018 Feb 13, 2019	SELL	$42.62 - $64.51 $432,081 - $654,002	-10,138 Reduced 59.39%	6,931 $313,000
Q3 2018 Nov 01, 2018	SELL	$57.63 - $65.87 $323,016 - $369,201	-5,605 Reduced 24.72%	17,069 $1.12 Million
Q2 2018 Aug 08, 2018	SELL	$54.05 - $67.23 $187,985 - $233,825	-3,478 Reduced 13.3%	22,674 $1.46 Million
Q1 2018 May 08, 2018	SELL	$46.55 - $57.38 $75,038 - $92,496	-1,612 Reduced 5.81%	26,152 $1.45 Million
Q4 2017 Feb 02, 2018	BUY	$46.22 - $51.77 $36,375 - $40,742	787 Added 2.92%	27,764 $1.33 Million
Q3 2017 Nov 13, 2017	BUY	$47.8 - $53.63 $1.29 Million - $1.45 Million	26,977	26,977 $1.36 Million

Others Institutions Holding IART

# of Institutions

229

Shares Held

79.4M

Call Options Held

19.4K

Put Options Held

View Full List

About INTEGRA LIFESCIENCES HOLDINGS CORP

Ticker IART
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 83,518,200
Market Cap $981M
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...

More about IART

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account